Comment on: “Prognostic performance of thymidine kinase 1 activity in patients with hormone receptor-positive and HER2-negative metastatic breast cancer treated with CDK4/6 and aromatase inhibitors”
本文未提供摘要，请点击“查看全文”查看完整内容。